Amazon has approved an expansion of commercial-stage pharmaceutical company Innovus Pharmaceuticals to Japan.
This move follows previous announcements for expansions of the online store to the UK, France, Germany, Spain and Italy.
Aiming for the first store to be opened by Q4 2019, the expansion is expected to strengthen Innovus Pharmaceuticals’ Amazon profile presence in Asia, adding to its current achievements in the US, Canada and Mexico.
Innovus Pharmaceuticals’ president and CEO Bassam Damaj said: “We are delighted with the approval of our new Amazon store in Japan.
“This expansion of our Amazon sales to Asia through Amazon’s Fulfillment by Amazon (FBA) shipping is a major step to globalise our direct sales without the need to continuously depend on finding local partners.
“The Japanese expansion of our Amazon stores follows the successful launches of our stores in the US, Canada, Mexico and the upcoming launches of our stores in Europe.”
Innovus Pharma is an over-the-counter (OTC) consumer goods and speciality pharmaceutical company that commercialises, licences and develops non-prescription medicine and consumer care products for men and women.
Earlier this month, Amazon signed a lease agreement to establish the Greenwood distribution centre in South Carolina, US.
Amazon will invest a total of $80m in the project, including the purchase of equipment such as conveyor systems, parcel sorters, racking systems, material-handling equipment and IT scanning and picking equipment.